Thromb Haemost 1969; 21(03): 534-545
DOI: 10.1055/s-0038-1653567
Originalarbeiten - Original Articles - Travaux Originaux
Schattauer GmbH

Recent Investigations on the Chemical Nature of Thromboplastin (“TP”) from Human Brain

E Hecht
1   University Hospital, Medical Department, Utrecht, The Netherlands
,
G Wijngaards1)
1   University Hospital, Medical Department, Utrecht, The Netherlands
› Author Affiliations
Further Information

Publication History

Publication Date:
10 June 2018 (online)

Summary

It was confirmed that purified thromboplastin from human brain tissue contains about 18 amino acids after hydrolysis.

The following observations gave rise to a discussion if these amino acids are to be considered as contaminations only, or if they derived from a protein moiety of brain thromboplastin.

The amino acids are present in all fractions of the thromboplastin and in the wash solutions, and their amount is very small.

The amino acids cannot be removed from thromboplastin with the usual techniques, but amino acids and peptides added on purpose can be separated again.

Investigations with DNFB pointed to the presence of a great number of precipitable small peptides of various composition. The possibility of the presence of a microamount of a long-chain peptide, or even a trace of protein could not be excluded.

Four techniques to separate the amino acid-rich fraction of thromboplastin were studied, described, and the results obtained compared. Sephadex G-25 was most successful, and the fractions were analysed.

Most striking was the percentage of aspartic acid in the non-lipid fraction, which is 13-26 times lower than that of proteins and lipoproteins.

The biological investigations of these fractions are subject of the subsequent paper.

1) Present address: State University of Utrecht, Department of Biochemistry , Utrecht, The Netherlands.


 
  • References

  • 1 Bartlett G. R. Phosphorus assay in column chromatography. J. biol. Chem 234: 466 1959;
  • 2 Biezenski J. J. A simple chromatographic technique for removal of non-lipid contaminations from lipid extracts. J. Lip. Res 03: 120 1962;
  • 3 Chargaff E. Studies on the mechanism of the thromboplastic effect. J. biol. Chem 173: 253 1948;
  • 3a Chargaff E, Moore D. H, Bendich A. Ultracentrifugal isolation from lung tissue of a macromolecular protein component with thromboplastic properties. J. biol. Chem 145: 593 1942;
  • 4 Deutsch E, Irsigler K, Lomoschitz H. Studien über Gewebsthromboplastin. 1. Reinigung, chemische Charakterisierung und Trennung in einen Eiweiß- und Lipoidanteil. Thrombos. Diathes. haemorrh. (Stuttg.) 12: 12 1964;
  • 5 Fiske C. H, Subbarow Y. The colorimetric determination of phosphorus. J. biol. Chem 66: 375 1925;
  • 6 Folch J, Lees M, Sloane-Stanley G. H. A simple method for preparation of total pure lipid extracts from brain. Fed. Proc 13: 209 1954;
  • 7 Fraenkel-Gonrat H, Harris J. I, Levy A. L. Glick D. Methods of Biochemical Analysis. Vol. 2, 359 Intersci. Publ; New York: 1955
  • 8 Fruton J. S, Simmonds S. General Biochemistry. John Wiley and Sons; New York: 1958
  • 9 Geigy A. G. Documenta Geigy Wissenschaftliche Tabellen. Basel. 1960
  • 10 Hecht E. Studien über den lipoiden Aktivator der Blutgerinnung. Thrombos. Diathes. haemorrh. (Stuttg.) 01: 380 1957;
  • 11 Hecht E. Colour reactions in chromatography. Clin. chim. Acta 13: 506 1966;
  • 12 Hecht E. Chemical nature of human brain thromboplastin. Nature (Lond.) 214: 197 1967;
  • 13 Hecht E, Oosterbaan-van Lit W. L. Über die chemische Natur des Thromboplastins aus menschlicher Hirnsubstanz. Thrombos. Diathes. haemorrh. (Stuttg.) 18: 223 1967;
  • 14 Hecht E, Wijngaards G. On the functional resynthesis of thromboplastin from its fractions and various substitutes. Thrombos. Diathes. haemorrh. (Stuttg.) 21: 546 1969;
  • 15 Hecht E, Gho M. H, Seegers W. H. Thromboplastin: nomenclature, and preparation of protein free material different from platelet factor 3 or lipid activator. Amer. J. Physiol 193: 584 1958;
  • 16 Irsigler K. Human brain thromboplastin. Thrombos. Diathes. haemorrh. (Stuttg.) 13: 433 1964;
  • 17 Kuhn R, Klesse P. Zur chemischen Konstitution des Lipoids der Thrombokinase. Naturwissenschaften 44: 352 1957;
  • 18 Margolis S, Langdon R. G. Studies on human serum β-lipoprotein. J. biol. Chem 241: 469 1966;
  • 19 Mills C. A. Chemical nature of tissue coagulins. J. biol. Chem 46: 135 1921;
  • 20 Piez K. A, Morris L. A modified procedure for the automatic analysis of amino acids. Anal. Biochem 01: 187 1966;
  • 21 Scanu A, Granda J. L. Effects of ultracentrifugation on the human serum high-density lipoprotein. Biochemistry 05: 446 1966;
  • 22 Seegers W. H. Prothrombin. Harvard University Press; 1962. Cambridge, Mass., U.S.A.:
  • 23 Stahl E. Dünnschicht-Chromatographie. Ein Laboratoriumshandbuch. Springer; Berlin: 1962
  • 24 Studer A. Contribution à l’étude de la thrombokinase. In: Festschrift Emil Barell. 229 E. Hoffmann-La Roche and Co; Basel: 1946
  • 25 Wagner H, Hörhammer L, Wolff P. Dünnschichtchromatographie von Phosphatiden und Glykolipiden. Biochem. Z 334: 175 1961;
  • 26 Weatherburn M. W. Phenol-hypochlorite reaction for determination of ammonia. Analyt. Chem 39: 971 1967;
  • 27 Wuthier R. E. Purification of lipids from nonlipid contaminants on Sephadex bead columns. J. Lip. Res 07: 558 1966;
  • 28 Wijngaards G, Hecht E. Detection and assays of proteins in the presence of lipids. (In preparation.)
  • 29 Zahler P. H, Wallach D. FHoelzl. Isolation of lipid-free plasma membrane proteins by gel filtration on Sephadex LH-20 using 2-ehloroethanol-water as solvent. Biochim. biophys. Acta (Amst.) 135: 371 1967;
  • 30 Zwaal R. F. A, van Deenen L. L. M. The solubilization of human erythrocyte membranes by n-pentanol. Biochim. biophys. Acta (Amst.) 150: 323 1968;